NDA 203026 describes VALSARTAN AND HYDROCHLOROTHIAZIDE, which is a drug marketed by
Alembic,
Amneal Pharms,
Apotex Inc,
Aurobindo Pharma Ltd,
Lupin Ltd,
Macleods Pharms Ltd,
Mylan Pharms Inc,
Prinston Inc,
Watson Labs Teva, and
Zydus Lifesciences, and is included in ten NDAs. It is available from
eighteen suppliers. Additional details are available on the
VALSARTAN AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in VALSARTAN AND HYDROCHLOROTHIAZIDE is
hydrochlorothiazide; valsartan. There are thirty-two
drug master file entries for this compound. Nineteen
suppliers are listed for this compound. Additional details are available on the
hydrochlorothiazide; valsartan profile page.